Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-042464
Filing Date
2013-08-02
Accepted
2013-08-02 14:03:35
Documents
1
Period of Report
2013-07-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd387208.html 3  
1 FORM 3 rrd387208.xml 3 10368
  Complete submission text file 0001181431-13-042464.txt   11826
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Issuer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LIPOCINE, INC. 675 ARAPEEN DRIVE, STE. 202 SALT LAKE CITY UT 84108
Business Address
Merrell Robert K. (Reporting) CIK: 0001579925 (see all company filings)

Type: 3 | Act: 34 | File No.: 333-178230 | Film No.: 131005877